PH
Insider
Peter Evan Harwin
DirectorPeter Evan Harwin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $133.5M of APGE (1,750,000 sh × $76.30, as filed), executed Jan 22.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$133.5M
shares × price, as filed
Last traded
Jan 22
Filed Jan 22
Median ADV $371.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $133.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
APGERecent filings
APGESALE
Apogee Therapeutics, Inc.
View filing →
$133.5M1,750,000 sh × $76.30
Exec Jan 22
Filed Jan 22 · 5:30 PM ET ZBIOPURCHASE Zenas BioPharma, Inc. View filing → $5.1M
300,000 sh × $17.00
Exec Sep 16 2024
Filed Sep 16 2024 · 5:30 PM ET